Home LiteratureArticle Details
PMID: 8223478 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

In vivo control of NF-kappa B activation by I kappa B alpha.

The EMBO journal ·Vol. 12 ·No. 12 ·1993-12-00 ·Pages 4685-95

Rice NR, Ernst MK

Abstract

The transcription factor NF-kappa B is stored in the cytoplasm in complexes with the inhibitor protein I kappa B alpha. It has been shown in vitro that dissociation of I kappa B alpha from these complexes results in active NF-kappa B. In this report we show that lipopolysaccharide (LPS)-induced activation of B or pre-B cells results in loss of I kappa B alpha from NF-kappa B complexes in vivo. Many liberated NF-kappa B dimers reached the nucleus, where increased c-rel, p65 and p50 were detected by immunoblotting and by DNA binding assays. Some liberated dimers were retained in the cytoplasm, however, through binding to newly synthesized I kappa B alpha, a finding which strongly suggests (i) that the LPS-induced signal causes dissociation of complexes rather than preventing their association and (ii) that dissociation results from modification of I kappa B alpha and not of c-rel or p65. No effect of LPS treatment was detected on p105 or p100, which also retain rel family members in the cytoplasm. Quite unexpectedly, we also found that in unstimulated cells there is a constant ongoing process of degradation and replacement of complexed I kappa B alpha. We propose that this turnover results in the low level of active NF-kappa B presumably necessary even in the unstimulated cell, and that the high rate of synthesis of I kappa B alpha provides the ability to turn off NF-kappa B activity rapidly as soon as the activating signal ceases.

MeSH Terms
Amino Acid Sequence Animals B-Lymphocytes/metabolism Base Sequence Cell Line DNA/metabolism DNA-Binding Proteins/metabolism Half-Life Humans I-kappa B Proteins Immunoblotting Lipopolysaccharides/pharmacology Mice Molecular Sequence Data NF-KappaB Inhibitor alpha NF-kappa B/metabolism Proto-Oncogene Proteins/metabolism Proto-Oncogene Proteins c-rel Transfection
Chemicals
DNA-Binding Proteins I-kappa B Proteins Lipopolysaccharides NF-kappa B NFKBIA protein, human Nfkbia protein, mouse Proto-Oncogene Proteins Proto-Oncogene Proteins c-rel NF-KappaB Inhibitor alpha DNA
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Rice N R
Laboratory of Molecular Virology and Carcinogenesis, NCI-Frederick Cancer Research and Development Center, Frederick, MD 21702-1201.
Ernst M K
References (54)
54 references, click to expand
  1. p105, the NF-kappa B p50 precursor protein, is one of the cellular proteins complexed with the v-Rel oncoprotein in transformed chicken spleen cells.
    J Virol. 1992 Jun;66(6):3758-67 PMID: 1533881
  2. Functional characterization of the NF-kappa B p65 transcriptional activator and an alternatively spliced derivative.
    Mol Cell Biol. 1992 Feb;12(2):444-54 PMID: 1732726
  3. Candidate proto-oncogene bcl-3 encodes a subunit-specific inhibitor of transcription factor NF-kappa B.
    Nature. 1992 Aug 13;358(6387):597-9 PMID: 1501714
  4. I kappa B interacts with the nuclear localization sequences of the subunits of NF-kappa B: a mechanism for cytoplasmic retention.
    Genes Dev. 1992 Oct;6(10):1899-913 PMID: 1340770
  5. The precursor of NF-kappa B p50 has I kappa B-like functions.
    Cell. 1992 Oct 16;71(2):243-53 PMID: 1423592
  6. Nuclear uptake control of NF-kappa B by MAD-3, an I kappa B protein present in the nucleus.
    EMBO J. 1993 Jan;12(1):201-11 PMID: 7679069
  7. NF-kappa B and Rel: participants in a multiform transcriptional regulatory system.
    Int Rev Cytol. 1993;143:1-62 PMID: 8449662
  8. NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway.
    Science. 1993 Mar 26;259(5103):1912-5 PMID: 8096091
  9. p105 and p98 precursor proteins play an active role in NF-kappa B-mediated signal transduction.
    Genes Dev. 1993 Apr;7(4):705-18 PMID: 8458581
  10. Mutual regulation of the transcriptional activator NF-kappa B and its inhibitor, I kappa B-alpha.
    Proc Natl Acad Sci U S A. 1993 Mar 15;90(6):2532-6 PMID: 8460169
  11. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I kappa B alpha: a mechanism for NF-kappa B activation.
    Mol Cell Biol. 1993 Jun;13(6):3301-10 PMID: 8497253
  12. Lipopolysaccharide induces phosphorylation of MAD3 and activation of c-Rel and related NF-kappa B proteins in human monocytic THP-1 cells.
    J Biol Chem. 1993 Jun 5;268(16):11803-10 PMID: 8505309
  13. The p65 subunit of NF-kappa B regulates I kappa B by two distinct mechanisms.
    Genes Dev. 1993 Jul;7(7A):1266-76 PMID: 8319912
  14. The DNA binding subunit of NF-kappa B is identical to factor KBF1 and homologous to the rel oncogene product.
    Cell. 1990 Sep 7;62(5):1007-18 PMID: 2203531
  15. Cloning of the p50 DNA binding subunit of NF-kappa B: homology to rel and dorsal.
    Cell. 1990 Sep 7;62(5):1019-29 PMID: 2203532
  16. Tumor necrosis factors-alpha and -beta bind to the same two types of tumor necrosis factor receptors and maximally activate the transcription factor NF-kappa B at low receptor occupancy and within minutes after receptor binding.
    J Biol Chem. 1990 Sep 5;265(25):15183-8 PMID: 2168404
  17. The mouse c-rel protein has an N-terminal regulatory domain and a C-terminal transcriptional transactivation domain.
    Mol Cell Biol. 1990 Oct;10(10):5473-85 PMID: 2204816
  18. New procedures for preparation and isolation of conjugates of proteins and a synthetic copolymer of D-amino acids and immunochemical characterization of such conjugates.
    Biochemistry. 1979 Feb 20;18(4):690-3 PMID: 84683
  19. A labile inhibitor blocks immunoglobulin kappa-light-chain-gene transcription in a pre-B leukemic cell line.
    Proc Natl Acad Sci U S A. 1986 Jan;83(2):295-8 PMID: 3079910
  20. Multiple nuclear factors interact with the immunoglobulin enhancer sequences.
    Cell. 1986 Aug 29;46(5):705-16 PMID: 3091258
  21. Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism.
    Cell. 1986 Dec 26;47(6):921-8 PMID: 3096580
  22. Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-kappa B transcription factor.
    Cell. 1988 Apr 22;53(2):211-7 PMID: 3129195
  23. In vitro activation and nuclear translocation of NF-kappa B catalyzed by cyclic AMP-dependent protein kinase and protein kinase C.
    Mol Cell Biol. 1989 Jun;9(6):2424-30 PMID: 2548081
  24. A 65-kappaD subunit of active NF-kappaB is required for inhibition of NF-kappaB by I kappaB.
    Genes Dev. 1989 Nov;3(11):1689-98 PMID: 2691328
  25. Activation of interleukin-6 gene expression through the NF-kappa B transcription factor.
    Mol Cell Biol. 1990 May;10(5):2327-34 PMID: 2183031
  26. Activation in vitro of NF-kappa B by phosphorylation of its inhibitor I kappa B.
    Nature. 1990 Apr 12;344(6267):678-82 PMID: 2157987
  27. Purified human I kappa B can rapidly dissociate the complex of the NF-kappa B transcription factor with its cognate DNA.
    Cell. 1990 Apr 20;61(2):255-65 PMID: 2184941
  28. RelB, a new Rel family transcription activator that can interact with p50-NF-kappa B.
    Mol Cell Biol. 1992 Feb;12(2):674-84 PMID: 1732739
  29. A novel mitogen-inducible gene product related to p50/p105-NF-kappa B participates in transactivation through a kappa B site.
    Mol Cell Biol. 1992 Feb;12(2):685-95 PMID: 1531086
  30. The characterization of the promoter of the gene encoding the p50 subunit of NF-kappa B indicates that it participates in its own regulation.
    EMBO J. 1992 Jan;11(1):195-203 PMID: 1740105
  31. A novel complex between the p65 subunit of NF-kappa B and c-Rel binds to a DNA element involved in the phorbol ester induction of the human urokinase gene.
    EMBO J. 1992 Jan;11(1):205-13 PMID: 1740106
  32. Distinct combinations of NF-kappa B subunits determine the specificity of transcriptional activation.
    Proc Natl Acad Sci U S A. 1992 Mar 1;89(5):1529-33 PMID: 1542644
  33. The 65-kDa subunit of human NF-kappa B functions as a potent transcriptional activator and a target for v-Rel-mediated repression.
    Proc Natl Acad Sci U S A. 1992 Mar 1;89(5):1875-9 PMID: 1542686
  34. I-Rel: a novel rel-related protein that inhibits NF-kappa B transcriptional activity.
    Genes Dev. 1992 May;6(5):745-60 PMID: 1577270
  35. Independent modes of transcriptional activation by the p50 and p65 subunits of NF-kappa B.
    Genes Dev. 1992 May;6(5):775-87 PMID: 1577272
  36. The v-rel oncogene encodes a kappa B enhancer binding protein that inhibits NF-kappa B function.
    Cell. 1990 Nov 16;63(4):803-14 PMID: 2225078
  37. Cloning of a mitogen-inducible gene encoding a kappa B DNA-binding protein with homology to the rel oncogene and to cell-cycle motifs.
    Nature. 1990 Nov 1;348(6296):76-80 PMID: 2234062
  38. Maintenance of NF-kappa B activity is dependent on protein synthesis and the continuous presence of external stimuli.
    Mol Cell Biol. 1991 Jan;11(1):259-66 PMID: 1986224
  39. Cloning of the DNA-binding subunit of human nuclear factor kappa B: the level of its mRNA is strongly regulated by phorbol ester or tumor necrosis factor alpha.
    Proc Natl Acad Sci U S A. 1991 Feb 1;88(3):966-70 PMID: 1992489
  40. Structure and autoregulation of the c-rel promoter.
    Oncogene. 1990 Dec;5(12):1843-50 PMID: 2284104
  41. DNA binding and I kappa B inhibition of the cloned p65 subunit of NF-kappa B, a rel-related polypeptide.
    Cell. 1991 Mar 8;64(5):961-9 PMID: 2001591
  42. Isolation of a rel-related human cDNA that potentially encodes the 65-kD subunit of NF-kappa B.
    Science. 1991 Mar 22;251(5000):1490-3 PMID: 2006423
  43. c-rel activates but v-rel suppresses transcription from kappa B sites.
    Proc Natl Acad Sci U S A. 1991 May 1;88(9):3715-9 PMID: 2023921
  44. The v-rel and c-rel proteins exist in high molecular weight complexes in avian and murine cells.
    Oncogene. 1991 Apr;6(4):615-26 PMID: 1851550
  45. NF-kappa B contacts DNA by a heterodimer of the p50 and p65 subunit.
    EMBO J. 1991 Jul;10(7):1817-25 PMID: 2050119
  46. Characterization of an immediate-early gene induced in adherent monocytes that encodes I kappa B-like activity.
    Cell. 1991 Jun 28;65(7):1281-9 PMID: 1829648
  47. The rel-associated pp40 protein prevents DNA binding of Rel and NF-kappa B: relationship with I kappa B beta and regulation by phosphorylation.
    Genes Dev. 1991 Aug;5(8):1464-76 PMID: 1907941
  48. Cloning of an NF-kappa B subunit which stimulates HIV transcription in synergy with p65.
    Nature. 1991 Aug 22;352(6337):733-6 PMID: 1876189
  49. Rel-associated pp40: an inhibitor of the rel family of transcription factors.
    Science. 1991 Sep 13;253(5025):1268-71 PMID: 1891714
  50. The p65 subunit is responsible for the strong transcription activating potential of NF-kappa B.
    EMBO J. 1991 Dec;10(12):3805-17 PMID: 1935902
  51. Generation of p50 subunit of NF-kappa B by processing of p105 through an ATP-dependent pathway.
    Nature. 1991 Dec 5;354(6352):395-8 PMID: 1956402
  52. B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-kappa B p50.
    Cell. 1991 Dec 20;67(6):1075-87 PMID: 1760839
  53. Repression of the chicken c-rel promoter by vRel in chicken embryo fibroblasts is not mediated through a consensus NF-kappa B binding site.
    Oncogene. 1991 Dec;6(12):2203-10 PMID: 1766669
  54. Rapid induction in regenerating liver of RL/IF-1 (an I kappa B that inhibits NF-kappa B, RelB-p50, and c-Rel-p50) and PHF, a novel kappa B site-binding complex.
    Mol Cell Biol. 1992 Jun;12(6):2898-908 PMID: 1588976
Article Info
Journal
The EMBO journal
Abbr.
EMBO J
ISSN
0261-4189
Published
1993-12-00
Pages
4685-95
Language
English
Region
England
NLM ID
8208664
PMCID
PMC413911
Subset
IM
Grants
NCI NIH HHS · N01-CO-74101 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com